Sign in
4

Changes in Ownership

Silence Therapeutics plc Filed Acc 0002048873-26-000002

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ede-Golightly James Director 2026-01-02 Grant or award · Share Option (Right to Buy) +90,000 90,000 D
Loading xslF345X05/form4-01062026_040108.xml…